Natbiome Speciality Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.60 Cr
as on 31-07-2024
- Paid Up Capital ₹ 2.60 Cr
as on 31-07-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.87 Cr
as on 31-07-2024
- Satisfied Charges ₹ 4.36 Cr
as on 31-07-2024
- Revenue -14.74%
(FY 2023)
- Profit -53.06%
(FY 2023)
- Ebitda 3.43%
(FY 2023)
- Net Worth 10.81%
(FY 2023)
- Total Assets 42.58%
(FY 2023)
About Natbiome Speciality Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.60 Cr and a paid-up capital of Rs 2.60 Cr.
The company currently has active open charges totaling ₹6.87 Cr. The company has closed loans amounting to ₹4.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rameshchandra Acharya and Dipenkumar Patel serve as directors at the Company.
- CIN/LLPIN
U15549GJ2016PTC094450
- Company No.
094450
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Natbiome Speciality Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rameshchandra Acharya  | Director | 21-Nov-2016 | Current |
| Dipenkumar Patel | Director | 21-Nov-2016 | Current |
Financial Performance of Natbiome Speciality Healthcare.
Natbiome Speciality Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.74% decrease. The company also saw a substantial fall in profitability, with a 53.06% decrease in profit. The company's net worth Soared by an impressive increase of 10.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natbiome Speciality Healthcare?
In 2023, Natbiome Speciality Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Integrity Solar Power (India) Private LimitedActive 12 years 9 monthsRameshchandra Acharya is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jan 2024 | ₹7.23 M | Open |
Others Creation Date: 17 Jan 2024 | ₹5.65 M | Open |
Sidbi Creation Date: 09 Jan 2024 | ₹2.68 M | Open |
How Many Employees Work at Natbiome Speciality Healthcare?
Unlock and access historical data on people associated with Natbiome Speciality Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natbiome Speciality Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natbiome Speciality Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
